Americas Total IV Solutions Market Size and Forecast (2021 - 2034), Regional Share, Trend, and Growth Opportunity Analysis

The Americas Total IV Solutions Market is anticipated to grow from US$ 4.91 billion in 2025 to US$ 10.41 billion by 2034, with a CAGR of 8.7% during 2026-2034.

The total IV solutions market growth is attributed to rising chronic disease prevalence and diabetes-related intravenous therapy needs, increasing hospitalization rates, surgical procedures, and emergency room visits, as well as the expansion of home healthcare and outpatient infusion services drive the adoption of total IV solutions.

The Americas total IV solutions market includes all intravenous fluids and drug delivery solutions used in hospitals, clinics, ambulatory surgical centers, and home care settings. Premixed IV drug solutions represent a key growth segment within the market due to their ready-to-use format, reduced pharmacy preparation requirements, lower risk of medication errors, and improved clinical efficiency. These solutions contain active pharmaceutical ingredients such as Paracetamol, Ciprofloxacin, Fluconazole, and Dexmedetomidine.

Non-premixed IV products, in comparison, require compounding from base fluids, concentrates, and admixture-based solutions before administration. IV solutions support essential healthcare functions, including fluid and electrolyte balance, medication delivery, nutritional support, pain management, anti-infective treatment, and sedation. Hospitals continue to dominate market demand because of increasing patient admissions, rising surgical volumes, and the growing burden of chronic diseases, while home care and outpatient facilities are increasingly adopting premixed IV solutions for efficient treatment delivery.

The total IV solutions market in North America is segmented into the US, Canada, and Mexico. North America is leading the total IV solutions market, driven by rising burden of chronic and infectious diseases, increasing hospitalizations, and continuous technological innovation in infusion systems. The Centers for Disease Control and Prevention (CDC) estimates that in 2023, over 39,000 new cases of HIV occurred in the US, with an estimated 1.13 million people currently receiving treatment for HIV (long-term IV) and require ongoing support through infusion-based therapies. Chronic diseases account for nearly 70% of all deaths in the US, thus providing continued demand for IV-based therapies for chronic conditions including but not limited to cancer, diabetes, and cardiovascular disease.

As of 2024, the CDC reported that linkage to care for HIV has increased to over 80%, providing evidence that the treatment portion of the HIV treatment continuum has grown considerably and reinforcing the necessity for infusion therapies in overall healthcare systems. Additionally, ongoing rates of hospital-acquired infections in the US continue to be a significant issue, as more than 250,000 bloodstream infections are associated with IV devices each year. This creates a greater need for advanced infusion solutions and the utilization of safe infusion practices. New product innovations, such as smart infusion pumps, ultrasound-guided access devices, and biologically resistant IV disposables, are providing hospitals and home care environments with greater safety and efficiency, ultimately increasing use.

Increased Use of IV Therapy in Oncology and Specialty Treatments to Provide Market Opportunities in Future

IV solutions are currently a very important part of the treatment of patients receiving treatment for cancer (oncology), immunotherapy and specialty care throughout the Americas. According to the Pan American Health Organization (PAHO), cancer is one of the leading causes of death in the Americas and will produce millions of new cases throughout the US, Brazil and Mexico (2023- 2025). Current guidelines for oncology treatment require the vast majority of doses of chemotherapy (or other treatments) will be given thru an IV. The US responded with an analysis from the Centres For Disease Control and Prevention (CDC) in 2024, indicating cancer is still placing an enormous burden on both (outpatient and inpatient) infusion services. Brazil's national cancer institute (Instituto Nacional de Cancer) reported in 2023-2024 that patient access to chemotherapy services has increased, resulting in a corresponding increase in the use of IV solutions. In Argentina, Chile and Colombia, there has been an expansion of oncology treatment access programs from 2023-2025 that resulted in an increase in the number of patients receiving IV-based oncologic treatments, as the growing use of IV solutions reflects a shift in therapeutic applications so that IV solutions have become an integral (rather than merely supportive care) part of complex treatment regimens in specialized care settings, resulting in increases in both the volume and frequency of use of IV solutions.

The US Food and Drug Administration, American Society of Health-System Pharmacists, Centers for Disease Control and Prevention, DATASUS, Pan American Health Organization are among the primary and secondary sources referred to while preparing the total IV solutions market report.

Reasons to Buy

Saves and reduces time required for identifying the market growth, size, leading players, and segments in the Americas Total IV Solutions market.
Highlights key business priorities to assist companies in realigning their business strategies
Emphasizes key findings and recommendations that uncover emerging industry trends in the Americas Total IV Solutions market, enabling stakeholders across the value chain to craft effective long-term strategies
Develop/modify business expansion plans by analyzing substantial growth prospects in mature and emerging markets
Scrutinizes in-depth Americas Total IV Solutions market trends, along with factors driving the market, as well as those hindering it
Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Executive Summary

1.1 Analyst Market Outlook
1.2 Market Attractiveness

2. Americas Total IV Solutions Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.2.1 Raw Material Suppliers / Components
2.2.2 Manufacturers Process / Technology
2.2.3 End-User
2.2.4 Level of Integration
2.3 Supply Chain Analysis
2.3.1 List of Manufacturers/Suppliers
2.3.2 List of Potential Customers
2.4 Porter`s Five Force Analysis
2.4.1 Threat of New Entrants - Low
2.4.2 Threat of Substitutes - Low to Moderate
2.4.3 Bargaining Power of Buyers - High
2.4.4 Bargaining Power of Suppliers - Moderate
2.4.5 Industry Rivalry - High
2.5 PEST Analysis
2.6 Import-Export Analysis for Key Countries (HS Code -300450, 300490, 901831)
2.6.1 Import-Export Analysis for Key Countries
2.7 Average Selling Price of Key Products Per Unit
2.8 Impact of Artificial Intelligence (AI)
2.9 Product or Technology Roadmap
2.10 Sustainability and ESG Trends
2.11 Patent Analysis
2.12 Regulatory Framework

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Concentration
3.3 Americas IV Solutions Market Share (%), by Company, 2025

4. Americas Total IV Solutions Market - Key Industry Dynamics

4.1 Market Drivers
4.1.1 Rising Burden of Chronic Diseases and Diabetes-Driven IV Therapy Demand
4.1.2 Increasing Hospitalization Rates, Surgical Procedures, and Emergency Care Utilization
4.1.3 Expanding Home Healthcare, Outpatient Infusion Services, and IV Product Innovation
4.2 Market Restraints
4.2.1 Recurrent IV Fluid Shortages and Fragile Supply Chain Dependency
4.2.2 Stringent Regulatory Requirements and Complex Approval Pathways
4.2.3 High Waste Generation, Cost Pressures, and Hospital Budget Constraints
4.3 Market Opportunities
4.3.1 Expansion of Local Manufacturing and Supply Chain Localization for IV Solutions
4.3.2 Technological Advancement in Sterile Manufacturing and Next-Generation IV Packaging Systems
4.3.3 Growth in Emergency Preparedness, Disaster Response, and Public Health Stockpiling Programs
4.4 Future Trends
4.4.1 Shift Toward Balanced Crystalloids Over Normal Saline in Clinical Practice
4.4.2 Increased Use of IV Therapy in Oncology and Specialty Treatments
4.4.3 Rise in Dehydration-Linked Conditions and Nutritional Deficiencies
4.5 Impact of Drivers and Restraints

5. Americas Total IV Solutions Market - Region Market Analysis

5.1 Americas Total IV Solutions Market Overview
5.2 Americas Total IV Solutions Market Revenue and Forecast (US$ Million), 2021-2034
5.3 Americas Total IV Solutions Market Revenue Forecast and Analysis

6. Americas Total IV Solutions Market Volume and Revenue Analysis - Drug Class

6.1 Americas Total IV Solutions Market Forecasts and Analysis by Drug Class
6.1.1 Non-Premixed IV
6.1.1.1.... Overview
6.1.1.2.... Non-Premixed IV: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
6.1.1.2.1 Non-premixed IV
6.1.1.2.1.1 Non-premixed IV: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
6.1.2 Premixed IV Products
6.1.2.1.... Overview
6.1.2.2.... Premixed IV Products: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
6.1.2.2.1 Premixed IV Products
6.1.2.2.1.1 Premixed IV Products: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
6.1.2.2.1.2 Drug-based Premixed IV Products By Products
6.1.2.2.1.2.1 Drug-based Premixed IV Products By Products: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
6.1.2.2.1.3 Drug-based Premixed IV Products By Formulation
6.1.2.2.1.3.1 Drug-based Premixed IV Products By Formulation: Americas Total IV Solutions Market - Revenue, 2021-2034 (Volume Million Units)
6.1.2.2.1.4 Drug-based Premixed IV Products By Formulation
6.1.2.2.1.4.1 Drug-based Premixed IV Products By Formulation: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
6.1.2.2.1.5 Drug-based Premixed IV Products By Application
6.1.2.2.1.5.1 Drug-based Premixed IV Products By Application: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
6.1.2.2.1.6 Drug-based Premixed IV Products By API
6.1.2.2.1.6.1 Drug-based Premixed IV Products By API: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
6.1.2.2.2 Premixed TPN Products
6.1.2.2.2.1 Premixed TPN Products: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)

7. Americas Total IV Solutions Market Volume and Revenue Analysis - End User

7.1 Americas Total IV Solutions Market Forecasts and Analysis by End User
7.1.1 Hospitals
7.1.1.1.... Overview
7.1.1.2.... Hospitals: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
7.1.2 Ambulatory Surgical Centers (ASCs)
7.1.2.1.... Overview
7.1.2.2.... Ambulatory Surgical Centers (ASCs): Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
7.1.3 Specialty Clinics
7.1.3.1.... Overview
7.1.3.2.... Specialty Clinics: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
7.1.4 Home Care Settings
7.1.4.1.... Overview
7.1.4.2.... Home Care Settings: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)
7.1.5 Others
7.1.5.1.... Overview
7.1.5.2.... Others: Americas Total IV Solutions Market - Revenue, 2021-2034 (US$ Million)

8. Americas Total IV Solutions Market - Country Analysis

8.1 North America Total IV Solutions Market Breakdown by Countries
8.1.1 United States Market
8.1.1.1.... United States: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.1.1.2.... United States: Americas Total IV Solutions Market - By Segmentation
8.1.1.2.1 Drug Class
8.1.1.2.1.1 Premixed IV Products
8.1.1.2.1.1.1 Drug-based Premixed IV Products By Products
8.1.1.2.1.1.2 Drug-based Premixed IV Products By Formulation
8.1.1.2.1.1.3 Drug-based Premixed IV Products By Application
8.1.1.2.1.1.4 Drug-based Premixed IV Products By API
8.1.1.2.1.2 Premixed TPN Products
8.1.1.2.2 Non-premixed IV By Type
8.1.1.2.3 End User
8.1.2 Canada Market
8.1.2.1.... Canada: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.1.2.2.... Canada: Americas Total IV Solutions Market - By Segmentation
8.1.2.2.1 Drug Class
8.1.2.2.1.1 Premixed IV Products
8.1.2.2.1.1.1 Drug-based Premixed IV Products By Products
8.1.2.2.1.1.2 Drug-based Premixed IV Products By Formulation
8.1.2.2.1.1.3 Drug-based Premixed IV Products By Application
8.1.2.2.1.1.4 Drug-based Premixed IV Products By API
8.1.2.2.1.2 Premixed TPN Products
8.1.2.2.2 Non-premixed IV By Type
8.1.2.2.3 End User
8.1.3 Mexico Market
8.1.3.1.... Mexico: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.1.3.2.... Mexico: Americas Total IV Solutions Market - By Segmentation
8.1.3.2.1 Drug Class
8.1.3.2.1.1 Premixed IV Products
8.1.3.2.1.1.1 Drug-based Premixed IV Products By Products
8.1.3.2.1.1.2 Drug-based Premixed IV Products By Formulation
8.1.3.2.1.1.3 Drug-based Premixed IV Products By Application
8.1.3.2.1.1.4 Drug-based Premixed IV Products By API
8.1.3.2.1.2 Premixed TPN Products
8.1.3.2.2 Non-premixed IV By Type
8.1.3.2.3 End User
8.2 South & Central America Total IV Solutions Market Breakdown by Countries
8.2.1 Brazil Market
8.2.1.1.... Brazil: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.1.2.... Brazil: Americas Total IV Solutions Market - By Segmentation
8.2.1.2.1 Drug Class
8.2.1.2.1.1 Premixed IV Products
8.2.1.2.1.1.1 Drug-based Premixed IV Products By Products
8.2.1.2.1.1.2 Drug-based Premixed IV Products By Formulation
8.2.1.2.1.1.3 Drug-based Premixed IV Products By Application
8.2.1.2.1.1.4 Drug-based Premixed IV Products By API
8.2.1.2.1.2 Premixed TPN Products
8.2.1.2.2 Non-premixed IV By Type
8.2.1.2.3 End User
8.2.2 Argentina Market
8.2.2.1.... Argentina: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.2.2.... Argentina: Americas Total IV Solutions Market - By Segmentation
8.2.2.2.1 Drug Class
8.2.2.2.1.1 Premixed IV Products
8.2.2.2.1.1.1 Drug-based Premixed IV Products By Products
8.2.2.2.1.1.2 Drug-based Premixed IV Products By Formulation
8.2.2.2.1.1.3 Drug-based Premixed IV Products By Application
8.2.2.2.1.1.4 Drug-based Premixed IV Products By API
8.2.2.2.1.2 Premixed TPN Products
8.2.2.2.2 Non-premixed IV By Type
8.2.2.2.3 End User
8.2.3 Chile Market
8.2.3.1.... Chile: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.3.2.... Chile: Americas Total IV Solutions Market - By Segmentation
8.2.3.2.1 Drug Class
8.2.3.2.1.1 Premixed IV Products
8.2.3.2.1.1.1 Drug-based Premixed IV Products By Products
8.2.3.2.1.1.2 Drug-based Premixed IV Products By Formulation
8.2.3.2.1.1.3 Drug-based Premixed IV Products By Application
8.2.3.2.1.1.4 Drug-based Premixed IV Products By API
8.2.3.2.2 Premixed TPN Products
8.2.3.2.3 Non-premixed IV By Type
8.2.3.2.4 End User
8.2.4 Colombia Market
8.2.4.1.... Colombia: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.4.2.... Colombia: Americas Total IV Solutions Market - By Segmentation
8.2.4.2.1 Drug Class
8.2.4.2.1.1 Premixed IV Products
8.2.4.2.1.1.1 Drug-based Premixed IV Products By Products
8.2.4.2.1.1.2 Drug-based Premixed IV Products By Formulation
8.2.4.2.2 Drug-based Premixed IV Products By Application
8.2.4.2.2.1.1 Drug-based Premixed IV Products By API
8.2.4.2.2.2 Premixed TPN Products
8.2.4.2.3 Non-premixed IV By Type
8.2.4.2.4 End User
8.2.5 Rest of South and Central America Market
8.2.5.1.... Rest of South and Central America: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.5.2.... Rest of South and Central America: Americas Total IV Solutions Market - By Segmentation
8.2.5.2.1 Drug Class
8.2.5.2.1.1 Premixed IV Products
8.2.5.2.2 Drug-based Premixed IV Products By Products
8.2.5.2.2.1.1 Drug-based Premixed IV Products By Formulation
8.2.5.2.2.1.2 Drug-based Premixed IV Products By Application
8.2.5.2.2.1.3 Drug-based Premixed IV Products By API
8.2.5.2.3 Premixed TPN Products
8.2.5.2.4 Non-premixed IV By Type
8.2.5.2.5 End User

9. Americas Total IV Solutions Market Industry Landscape

10. Americas Total IV Solutions Market - Key Company Profiles

10.1 Baxter International Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Fresenius Kabi AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 B. Braun Melsungen AG
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 ICU Medical Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Xellia Pharmaceuticals ApS
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Grifols SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Mallinckrodt Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Terumo Corp
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 JW Life Science
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
10.11 Amanta Healthcare
10.11.1 Key Facts
10.11.2 Business Description
10.11.3 Products and Services
10.11.4 Financial Overview
Amanta Healthcare financials are not available in the public domain.
10.11.5 SWOT Analysis
10.11.6 Key Developments

11. List of Additional Companies Analyzed

11.1 List of Additional Companies Analyzed

12. Appendix

12.1 Glossary
12.2 Research Methodology and Approach
12.2.1 Secondary Research
12.2.2 Primary Research
12.2.3 Market Estimation Approach
12.2.3.1.. Supply Side Analysis
12.2.3.2.. Demand Side Analysis
12.2.4 Research Assumptions and Limitations
12.2.5 Currency Conversion
12.3 About the Analyst

12. 4 Market Intelligence Cloud

LIST OF TABLES

Table 1. Import Analysis by HS Code 300450, 2024
Table 2. Export Analysis by HS Code 300490, 2024
Table 3. Import Analysis by HS Code 901831, 2024
Table 4. Average Selling Price of Key Products Per Unit
Table 5. List of Patents and Description
Table 6. List of Regulatory Bodies and Organizations
Table 7. Ease of Doing Business: Key Country Rankings
Table 8. Market Share Analysis, 2025 - By Key Players
Table 9. Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million)
Table 10. Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million)
Table 11. Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug Class
Table 12. Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug Class
Table 13. Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Non-premixed IV By Type
Table 14. Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Non-premixed IV By Type
Table 15. Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed IV Products
Table 16. Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed IV Products
Table 17. Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 18. Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 19. Americas Total IV Solutions Market - Volume, 2021 - 2025 (Million Units) - by Drug-based Premixed IV Products By Formulation
Table 20. Americas Total IV Solutions Market - Volume, 2026 - 2034 (Million Units) - by Drug-based Premixed IV Products By Formulation
Table 21. Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 22. Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 23. Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 24. Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 25. Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By API
Table 26. Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By API
Table 27. Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed TPN Products
Table 28. Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed TPN Products
Table 29. Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 30. Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 31. North America Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Country
Table 32. North America Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
Table 33. United States: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug Class
Table 34. United States: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug Class
Table 35. United States: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed IV Products
Table 36. United States: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed IV Products
Table 37. United States: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 38. United States: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 39. United States: Americas Total IV Solutions Market - Volume, 2021 - 2025 (Million Units) - by United States
Table 40. United States: Americas Total IV Solutions Market - Volume Forecast, 2026 - 2034 (Million Units) - by United States
Table 41. United States: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 42. United States: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 43. United States: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 44. United States: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 45. United States: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By API
Table 46. United States: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By API
Table 47. United States: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed TPN Products
Table 48. United States: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed TPN Products
Table 49. United States: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Non-premixed IV By Type
Table 50. United States: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Non-premixed IV By Type
Table 51. United States: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 52. United States: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 53. Canada: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug Class
Table 54. Canada: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug Class
Table 55. Canada: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed IV Products
Table 56. Canada: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed IV Products
Table 57. Canada: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 58. Canada: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 59. Canada: Americas Total IV Solutions Market - Volume, 2021 - 2025 (Million Units) - by Canada
Table 60. Canada: Americas Total IV Solutions Market - Volume Forecast, 2026 - 2034 (Million Units) - by Canada
Table 61. Canada: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 62. Canada: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 63. Canada: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 64. Canada: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 65. Canada: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By API
Table 66. Canada: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By API
Table 67. Canada: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed TPN Products
Table 68. Canada: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed TPN Products
Table 69. Canada: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Non-premixed IV By Type
Table 70. Canada: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Non-premixed IV By Type
Table 71. Canada: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 72. Canada: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 73. Mexico: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug Class
Table 74. Mexico: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug Class
Table 75. Mexico: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed IV Products
Table 76. Mexico: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed IV Products
Table 77. Mexico: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 78. Mexico: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 79. Mexico: Americas Total IV Solutions Market - Volume, 2021 - 2025 (Million Units) - by Mexico
Table 80. Mexico: Americas Total IV Solutions Market - Volume Forecast, 2026 - 2034 (Million Units) - by Mexico
Table 81. Mexico: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 82. Mexico: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 83. Mexico: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 84. Mexico: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 85. Mexico: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By API
Table 86. Mexico: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By API
Table 87. Mexico: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed TPN Products
Table 88. Mexico: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed TPN Products
Table 89. Mexico: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Non-premixed IV By Type
Table 90. Mexico: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Non-premixed IV By Type
Table 91. Mexico: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 92. Mexico: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 93. South & Central America Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Country
Table 94. South & Central America Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
Table 95. Brazil: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug Class
Table 96. Brazil: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug Class
Table 97. Brazil: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed IV Products
Table 98. Brazil: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed IV Products
Table 99. Brazil: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 100. Brazil: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 101. Brazil: Americas Total IV Solutions Market - Volume, 2021 - 2025 (Million Units) - by Brazil
Table 102. Brazil: Americas Total IV Solutions Market - Volume Forecast, 2026 - 2034 (Million Units) - by Brazil
Table 103. Brazil: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 104. Brazil: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 105. Brazil: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 106. Brazil: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 107. Brazil: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By API
Table 108. Brazil: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By API
Table 109. Brazil: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed TPN Products
Table 110. Brazil: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed TPN Products
Table 111. Brazil: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Non-premixed IV By Type
Table 112. Brazil: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Non-premixed IV By Type
Table 113. Brazil: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 114. Brazil: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 115. Argentina: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug Class
Table 116. Argentina: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug Class
Table 117. Argentina: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed IV Products
Table 118. Argentina: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed IV Products
Table 119. Argentina: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 120. Argentina: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 121. Argentina: Americas Total IV Solutions Market - Volume, 2021 - 2025 (Million Units) - by Argentina
Table 122. Argentina: Americas Total IV Solutions Market - Volume Forecast, 2026 - 2034 (Million Units) - by Argentina
Table 123. Argentina: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 124. Argentina: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 125. Argentina: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 126. Argentina: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 127. Argentina: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By API
Table 128. Argentina: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By API
Table 129. Argentina: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed TPN Products
Table 130. Argentina: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed TPN Products
Table 131. Argentina: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Non-premixed IV By Type
Table 132. Argentina: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Non-premixed IV By Type
Table 133. Argentina: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 134. Argentina: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 135. Chile: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug Class
Table 136. Chile: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug Class
Table 137. Chile: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed IV Products
Table 138. Chile: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed IV Products
Table 139. Chile: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 140. Chile: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 141. Chile: Americas Total IV Solutions Market - Volume, 2021 - 2025 (Million Units) - by Chile
Table 142. Chile: Americas Total IV Solutions Market - Volume Forecast, 2026 - 2034 (Million Units) - by Chile
Table 143. Chile: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 144. Chile: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 145. Chile: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 146. Chile: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 147. Chile: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By API
Table 148. Chile: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By API
Table 149. Chile: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed TPN Products
Table 150. Chile: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed TPN Products
Table 151. Chile: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Non-premixed IV By Type
Table 152. Chile: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Non-premixed IV By Type
Table 153. Chile: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 154. Chile: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 155. Colombia: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug Class
Table 156. Colombia: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug Class
Table 157. Colombia: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed IV Products
Table 158. Colombia: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed IV Products
Table 159. Colombia: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 160. Colombia: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 161. Colombia: Americas Total IV Solutions Market - Volume, 2021 - 2025 (Million Units) - by Colombia
Table 162. Colombia: Americas Total IV Solutions Market - Volume Forecast, 2026 - 2034 (Million Units) - by Colombia
Table 163. Colombia: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 164. Colombia: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 165. Colombia: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 166. Colombia: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 167. Colombia: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By API
Table 168. Colombia: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By API
Table 169. Colombia: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed TPN Products
Table 170. Colombia: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed TPN Products
Table 171. Colombia: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Non-premixed IV By Type
Table 172. Colombia: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Non-premixed IV By Type
Table 173. Colombia: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 174. Colombia: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 175. Rest of South and Central America: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug Class
Table 176. Rest of South and Central America: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug Class
Table 177. Rest of South and Central America: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed IV Products
Table 178. Rest of South and Central America: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed IV Products
Table 179. Rest of South and Central America: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 180. Rest of South and Central America: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Products
Table 181. Rest of South and Central America: Americas Total IV Solutions Market - Volume, 2021 - 2025 (Million Units) - by Rest of South and Central America
Table 182. Rest of South and Central America: Americas Total IV Solutions Market - Volume Forecast, 2026 - 2034 (Million Units) - by Rest of South and Central America
Table 183. Rest of South and Central America: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 184. Rest of South and Central America: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Formulation
Table 185. Rest of South and Central America: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 186. Rest of South and Central America: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By Application
Table 187. Rest of South and Central America: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Drug-based Premixed IV Products By API
Table 188. Rest of South and Central America: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Drug-based Premixed IV Products By API
Table 189. Rest of South and Central America: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Premixed TPN Products
Table 190. Rest of South and Central America: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Premixed TPN Products
Table 191. Rest of South and Central America: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by Non-premixed IV By Type
Table 192. Rest of South and Central America: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by Non-premixed IV By Type
Table 193. Rest of South and Central America: Americas Total IV Solutions Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 194. Rest of South and Central America: Americas Total IV Solutions Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 195. List of Additional Companies Analyzed
Table 196. Glossary - Americas Total IV Solutions Market

LIST OF FIGURES

Figure 1. Americas Total IV Solutions Market Segmentation.
Figure 2. Americas Total IV Solutions Market - Value Chain Analysis
Figure 3. Porter’s Five Forces Analysis
Figure 4. Pest Analysis
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Americas Total IV Solutions Market Revenue and Forecast (US$ Million), 2021-2034
Figure 7. Americas Total IV Solutions Market Share (%) - by Drug Class (2025 and 2034)
Figure 8. Non-Premixed IV: Americas Total IV Solutions Market - Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 9. Premixed IV Products: Americas Total IV Solutions Market - Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 10. Americas Total IV Solutions Market Share (%) - by End User (2025 and 2034)
Figure 11. Hospitals: Americas Total IV Solutions Market - Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 12. Ambulatory Surgical Centers (ASCs): Americas Total IV Solutions Market - Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 13. Specialty Clinics: Americas Total IV Solutions Market - Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 14. Home Care Settings: Americas Total IV Solutions Market - Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 15. Others: Americas Total IV Solutions Market - Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 16. North Americas Total IV Solutions Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 17. United States: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 18. Canada: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 19. Mexico: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 20. South & Central America Total IV Solutions Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 21. Brazil: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 22. Argentina: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 23. Chile: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 24. Colombia: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 25. Rest of South and Central America: Americas Total IV Solutions Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 26. Bottom-Up Approach and Top-Down Approach

Companies

The List of Companies - Americas Total IV Solutions Market

Baxter International Inc
Fresenius Kabi AG
Pfizer Inc
B. Braun Melsungen AG
ICU Medical Inc
Xellia Pharmaceuticals ApS
Grifols SA
Mallinckrodt Plc / Endo Inc
Terumo Corp
JW Life Science
Amanta Healthcare

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3171EUR$3,450USD£2,696GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4091EUR$4,450USD£3,478GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5010EUR$5,450USD£4,259GBP

Increased Use of IV Therapy in Oncology and Specialty Treatments to Provide Market Opportunities in Future

Reasons to Buy

Table of Contents

Companies

Related Topics

Related Reports

Intravenous (IV) Therapy and Vein Access Market

Intravenous (IV) Solutions - Global Strategic Business Report

Intravenous Solutions Market Outlook, 2030

Large Volume Parenteral (LVP) Market Report 2026

Home Infusion Therapy Market - Forecasts from 2023 to 2028